The synergy between Robotic Process Automation (RPA) and Microfluidic POCT is creating a new gold standard in the IVD industry. Microfluidic chips handle the complex fluid dynamics of biological samples, while RPA systems handle the high-throughput production and automated testing of these chips during the QA phase. This combination ensures that every single microfluidic cartridge performs flawlessly in the field, making rapid two-step PCR testing reliable and accessible for decentralized clinics worldwide.